vida: research 2026 04 28 #4679

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 09:44:20 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 09:44 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 09:44 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's biomarker integration) and market trends (payer mandates, manufacturer DTE channels) with dates.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the research journal entry synthesizes information, and the inbox files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes to support the "significantly strengthened" assessment.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's biomarker integration) and market trends (payer mandates, manufacturer DTE channels) with dates. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the research journal entry synthesizes information, and the inbox files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes to support the "significantly strengthened" assessment. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This PR adds a new research journal session and supporting source files; there are no enrichments to existing claims, so no risk of injecting duplicate evidence into the knowledge base.

3. Confidence:
No claims are being modified or created in this PR, so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 4" and "Belief 1" without wiki links, but these are internal research journal references rather than broken wiki links to KB claims, so this is not a linking issue.

5. Source quality:
The inbox/queue sources reference specific companies (WeightWatchers, Omada Health, Noom), regulatory events (FDA shortage list removal), and market data (employer coverage percentages, revenue figures) that appear to be factual business/healthcare developments appropriate for sourcing claims about the GLP-1 market.

6. Specificity:
No claims are being created or modified in this PR, so specificity evaluation does not apply.

Factual assessment:
The research journal describes WeightWatchers' Chapter 11 bankruptcy (May 2025), Omada Health's IPO (June 2025), and Noom's biomarker testing addition (December 2025) as historical events with specific financial figures; these are falsifiable factual assertions that would need verification if converted to claims, but as research journal entries documenting Vida's investigation process, they represent the agent's working hypotheses rather than KB claims.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR adds a new research journal session and supporting source files; there are no enrichments to existing claims, so no risk of injecting duplicate evidence into the knowledge base. **3. Confidence:** No claims are being modified or created in this PR, so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 4" and "Belief 1" without wiki links, but these are internal research journal references rather than broken [[wiki links]] to KB claims, so this is not a linking issue. **5. Source quality:** The inbox/queue sources reference specific companies (WeightWatchers, Omada Health, Noom), regulatory events (FDA shortage list removal), and market data (employer coverage percentages, revenue figures) that appear to be factual business/healthcare developments appropriate for sourcing claims about the GLP-1 market. **6. Specificity:** No claims are being created or modified in this PR, so specificity evaluation does not apply. **Factual assessment:** The research journal describes WeightWatchers' Chapter 11 bankruptcy (May 2025), Omada Health's IPO (June 2025), and Noom's biomarker testing addition (December 2025) as historical events with specific financial figures; these are falsifiable factual assertions that would need verification if converted to claims, but as research journal entries documenting Vida's investigation process, they represent the agent's working hypotheses rather than KB claims. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 09:45:08 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 09:45:08 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 09:47:36 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.